首页|七味都气丸加味辅助布地奈德福莫特罗粉吸入剂联合噻托溴铵对重度慢性阻塞性肺疾病肺功能、血肌酐、免疫因子及T淋巴细胞亚群表达水平的影响

七味都气丸加味辅助布地奈德福莫特罗粉吸入剂联合噻托溴铵对重度慢性阻塞性肺疾病肺功能、血肌酐、免疫因子及T淋巴细胞亚群表达水平的影响

扫码查看
目的 分析七味都气丸加味辅助布地奈德福莫特罗粉吸入剂联合噻托溴铵对重度慢性阻塞性肺疾病(COPD)患者肺功能、血肌酐、免疫因子及T淋巴细胞亚群表达水平的影响。方法 选取于2018年11月-2020年11月期间医院(凉山州中西医结合医院)收治的老年COPD患者106例,按照治疗方式不同将患者分为观察组(七味都气丸加味+布地奈德福莫特罗粉吸入剂+噻托溴铵治疗)与对照组(布地奈德福莫特罗粉吸入剂联合噻托溴铵治疗),各53例。比较两组患者治疗前后C-反应蛋白(CRP)、降钙素原(PCT)、可溶性髓系细胞表达触发蛋白-1(sTREM-1)、白细胞介素-6(IL-6)和白细胞介素-10(IL-10)炎性因子,以及CD4+、CD8+、CD4+/CD8+、PaO2、PaCO2、心率及呼吸频率的变化、第1秒用力呼气容积(FEV1)/用力肺活量(FVC)、FEV1%pred、血肌酐、最大自主通气量(MVV)。观察并记录两组患者用药期间药物相关不良反应的发生情况。结果 观察组治疗总有效率为94。34%(50/53),显著高于对照组(77。36%,41/53)(P<0。05)。观察组不良反应发生率为9。43%(5/53),显著低于对照组(22。64%,12/53)(P<0。05)。治疗后,观察组CRP、PCT、sTREM-1、IL-6及IL-10炎性因子水平改善效果显著优于对照组(P<0。05)。观察组CD4+和CD4+/CD8+水平改善效果显著优于对照组(P<0。05)。治疗后,观察组PaO2高于本组治疗前和同期对照组,PaCO2、心率和呼吸频率低于对照组(P<0。05)。治疗后,观察组FEV1/FVC、FEV1%pred和MVV高于对照组,血肌酐低于对照组(P<0。05)。结论 七味都气丸加味辅助布地奈德福莫特罗粉吸入剂联合噻托溴铵对重度COPD患者的疗效更佳,快速缓解患者体征与临床症状,不良反应较少,可以显著改善患者机体的炎性因子水平、肺功能、血肌酐及T淋巴细胞亚群水平,值得采用。
Effects of Modified Qiwei Duqi Pills(七味都气丸加味)Assisting Budesonide Formoterol Powder Inhaler Combined with Tiotropium Bromide on Pulmonary Function,Serum Creatinine,Immune Factors and T Lymphocyte Subsets Expression Levels in Patients with Severe COPD
Objective To analyze the effects of Modified Qiwei Duqi Pills(七味都气丸加味)assisting budesonide formoterol powder inhaler combined with tiotropium bromide on pulmonary function,serum creatinine,immune factors and T lymphocyte sub-sets expression levels in patients with severe chronic obstructive pulmonary disease(COPD).Methods A total of 106 elderly COPD patients admitted to the hospital from November 2018 to November 2020 were selected,and the patients were divided into observation group(Modified Qiwei Duqi Pills assisting budesonide formoterol powder inhaler+tiotropium bromide)and control group(budesonide formoterol powder inhaler combined with tiotropium bromide),53 cases in each.The levels of C-reactive protein(CRP),procalcitonin(PCT),soluble myeloid cell expression trigger protein-1(sTREM-1),interleukin-6(IL-6)and interleukin-10(IL-10),the values of CD4+,CD8+,CD4+/CD8+,PaO2,PaCO2,heart rate,respiratory rate,forced expiratory vol-ume in the first second(FEV1)/forced vital capacity(FVC),FEV1%pred,serum creatinine and maximum voluntary ventilation(MVV)before and after treatment between the two groups were compared.The occurrence of drug-related adverse reactions during the two groups was observed and recorded.Results The total effective rate of the observation group was 94.34%(50/53),which was significantly higher than that of the control group(77.36%,41/53)(P<0.05).The incidence of adverse reactions in the observation group was 9.43%(5/53),which was significantly lower than 22.64%(12/53)in the control group(P<0.05).After treatment,the improvement effect of CRP,PCT,sTREM-1,IL-6 and IL-10 in the observation group was significantly better than that in the control group(P<0.05).The improvement effect of CD4+and CD4+/CD8+in the observation group was significantly better than that in the control group(P<0.05).After treatment,the value of PaO2 in the observation group was higher than that in the control group before treatment and in the same period,while the values of PaCO2,heart rate and respiratory rate were lower than those in the control group(P<0.05).After treatment,the values of FEV1/FVC,FEV1%pred and MVV in the observation group were higher than those in the control group,and the level of serum creatinine was lower than that in the con-trol group(P<0.05).Conclusion Modified Qiwei Duqi Pills assisting adjuvant budesonide formoterol powder inhalant combined with tiotropium bromide has better efficacy in patients with severe COPD.It can rapidly relieve the signs and clinical symptoms of patients with fewer adverse reactions,and can significantly improve the levels of inflammatory factors,lung function,blood creati-nine and T lymphocyte subgroup of patients,and it is worthy of use.

Modified Qiwei Duqi Pills(七味都气丸)budesonide formoteroltiotropium bromidechronic obstructive pulmo-nary diseaseT lymphocytescurative effect

花荣、张家春、胡金秀

展开 >

成都市第六人民医院,四川成都 610051

七味都气丸 布地奈德福莫特罗 噻托溴铵 慢性阻塞性肺疾病 T淋巴细胞 疗效

四川省卫生和计划生育委员会科研项目

18PJ441

2024

中华中医药学刊
中华中医药学会 ,辽宁中医药大学

中华中医药学刊

CSTPCD北大核心
影响因子:1.007
ISSN:1673-7717
年,卷(期):2024.42(8)